Skip to content

Retrospective study to assess renal function using MAG3 renogram in patients with renal tumor who treated by carbon ion radiotherapy

Retrospective study to assess renal function using MAG3 renogram in patients with renal tumor who treated by carbon ion radiotherapy - Retrospective study to assess renal function using MAG3 renogram in patients with renal tumor who treated by carbon ion radiotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000039928
Enrollment
20
Registered
2020-04-01
Start date
2020-03-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal tumor

Interventions

None listed

Sponsors

National Institute of Radiological Sciences (NIRS), QST
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients underwent MAG3 renogram, among who were treated with carbon ion radiotherapy for renal tumors from January 2014 to March 2020 at QST hospital.

Exclusion criteria

Exclusion criteria: 1.Other cause of death within 12 months after carbon ion radiotherapy. 2.Patients who were received other anticancer treatments within 4 months after carbon ion radiotherapy. 3.Patients who refuse to participate in this study.

Design outcomes

Primary

MeasureTime frame
Assessment of diagnostic abilities of MAG3 renogram in terms of prediction of renal function before and after(up to 7 years) carbon ion radiotherapy

Secondary

MeasureTime frame
Correlation among renal function predicted by MAG3 renogram and renal function index by prognosis, imaging

Countries

Japan

Contacts

Public ContactKana Yamazaki

National Institute of Radiological Sciences (NIRS), QST Dept. of Molecular Imaging and Theranostics

yamazaki.kana@qst.go.jp043-206-4076

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026